Last reviewed · How we verify
Traditional Chinese Medicine Formula LC09 — Competitive Intelligence Brief
phase 3
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Traditional Chinese Medicine Formula LC09 (Traditional Chinese Medicine Formula LC09) — China-Japan Friendship Hospital. LC09 is a Traditional Chinese Medicine Formula that modulates the immune system.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Traditional Chinese Medicine Formula LC09 TARGET | Traditional Chinese Medicine Formula LC09 | China-Japan Friendship Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Traditional Chinese Medicine Formula LC09 CI watch — RSS
- Traditional Chinese Medicine Formula LC09 CI watch — Atom
- Traditional Chinese Medicine Formula LC09 CI watch — JSON
- Traditional Chinese Medicine Formula LC09 alone — RSS
Cite this brief
Drug Landscape (2026). Traditional Chinese Medicine Formula LC09 — Competitive Intelligence Brief. https://druglandscape.com/ci/traditional-chinese-medicine-formula-lc09. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab